FAS Wealth Partners’s Boston Scientific BSX Stock Holding History

FAS Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$457K	Buy	7,277 +11	+0.2%	+$880	0.03%	240
2025 Q4	$693K	Sell	7,266 -9	-0.1%	-$882	0.04%	204
2025 Q3	$710K	Sell	7,275 -6	-0.1%	-$621	0.05%	194
2025 Q2	$782K	Buy	7,281 +15	+0.2%	+$1.52K	0.06%	180
2025 Q1	$733K	Hold	7,266	–	–	0.06%	172
2024 Q4	$649K	Sell	7,266 -14,235	-66%	-$1.25M	0.05%	183
2024 Q3	$1.8M	Buy	21,501 +14,235	+196%	+$1.12M	0.14%	122
2024 Q2	$560K	Hold	7,266	–	–	0.05%	194
2024 Q1	$498K	Buy	7,266 +137	+2%	+$8.81K	0.04%	207
2023 Q4	$412K	Hold	7,129	–	–	0.04%	214
2023 Q3	$376K	Buy	7,129 +285	+4%	+$14.9K	0.04%	213
2023 Q2	$370K	Buy	6,844 +135	+2%	+$7.05K	0.05%	194
2023 Q1	$336K	Hold	6,709	–	–	0.04%	224
2022 Q4	$310K	Sell	6,709 -96	-1%	-$4.16K	0.04%	238
2022 Q3	$264K	Sell	6,805 -5,807	-46%	-$233K	0.03%	241
2022 Q2	$470K	Buy	+12,612	New	+$513K	0.05%	189

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FAS Wealth Partners's BSX Position: Q1 2026 in Review

FAS Wealth Partners increased its Boston Scientific (BSX) stake by 0.15% in Q1 2026, buying an estimated $880 and bringing the position to 7,277 shares worth $457K. The position accounts for 0.03% of the portfolio, ranked #240.

FAS Wealth Partners first reported a position in BSX in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.8M in Q3 2024. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

FAS Wealth Partners held 7,277 shares of Boston Scientific worth $457K as of Q1 2026.
FAS Wealth Partners bought 11 Boston Scientific shares in Q1 2026, an estimated $880.
Boston Scientific made up 0.03% of FAS Wealth Partners's portfolio in Q1 2026, its #240 holding.
FAS Wealth Partners first reported a position in Boston Scientific in Q2 2022 and has held it in 16 quarters since.
FAS Wealth Partners's Boston Scientific position peaked at $1.8M in Q3 2024.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on FAS Wealth Partners's 13F filing for Q1 2026, filed 10 Jun 2026.